NVG-hIL15

品系全名

NOD.Cg-PrkdcscidIl2rgem1SmocIl15em1(hIL15)Smoc

目錄號(hào)

GM-NVG-210001

品系狀態(tài)

活體

導(dǎo)出PDF

基因信息

基因名
Il15

品系描述

通過(guò)同源重組,將小鼠Il15基因進(jìn)行人源化修飾。

應(yīng)用領(lǐng)域:腫瘤研究,免疫治療;藥物篩選

驗(yàn)證數(shù)據(jù)

Human IL15 expression analysis

image.png

Fig 1. Human IL15 expression analysis in homozygous NVG-hIL15 mice by ELISA.?

image.png

Fig 2. Humanized immune reconstitution levels and body weight growth curves in huPBMC-NVG-hIL15 mice.

image.png

Fig 3. Humanized immune reconstitution levels in huPBNK-NVG-hIL15 mice.

image.png

Fig 4. Efficacy evaluation of CD20-targeting antibody using Raji huPBNK model.

image.png

Fig 5. Functional protein detection in NK cells in the presence of anti-hCD20 antibody drug using Raji huPBNK model.

image.png

Fig 6. ADCC efficacy research in vitro using huPBNK model.

image.png

Fig 7. Body weight growth curves in γδT-NVG-hIL15 mice.

image.png

Fig 8. Survial rates in γδT-NVG-hIL15 mice.

image.png

Fig 9. Humanized immune reconstitution levels in γδT-NVG-hIL15 mice.

image.png

Fig 10. Humanized immune reconstitution levels in huHSC-NVG-hIL15 mice. A. hCD45+ cell and mCD45+ cell in PB. B. hCD3+, hCD19+, hCD56+, hCD33+, hCD33+hCD14+, hCD33+ hCD66b+ cell in hCD45+ cell.?


你也可能感興趣

Tamoxifen誘導(dǎo)Cre-ERT2小鼠 使用指南

Cre-ERT2在無(wú)Tamoxifen誘導(dǎo)的情況下,在細(xì)胞質(zhì)內(nèi)處于無(wú)活性狀態(tài);當(dāng)Tamoxifen誘導(dǎo)后,Tamoxifen的代謝產(chǎn)物4-OHT(雌激素類似物)與ERT結(jié)合,可使Cre-ERT2進(jìn)核發(fā)揮Cre重組酶活性。

查看
【小鼠大學(xué)問(wèn)】基因工程小鼠的命名規(guī)則

常見(jiàn)的基因工程小鼠可以分為兩種命名方式,包括基因定點(diǎn)修飾的小鼠命名,比如:敲除、敲入、點(diǎn)突變等等,和隨機(jī)轉(zhuǎn)基因的小鼠命名。

查看